Z (Z)

$10.6B
Market Cap
484.4
P/E Ratio
2.14
Beta
Dividend Yield
Piotroski 7/9Altman Z 8.2 SafeBeneish M -2.30 Clean

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 7/9, Altman Z 8.2 (above 3.0 safe zone threshold).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics present a stark dichotomy between robust operational momentum and severely depressed capital efficiency. While the company demonstrates strong revenue expansion of 15.5% year-over-year, supported by exceptional gross margins at 74.1%, its ability to convert assets into returns is critically impaired; an ROIC of merely 0.7% coupled with a DuPont decomposition revealing low asset turnover (0.45x) and minimal leverage indicates that earnings are being generated without efficient capital deployment or significant financial engineering. Despite this operational inefficiency, the balance sheet appears secure given an Altman Z-Score of 8.2 and a Beneish M-Score of -2.30 suggesting low manipulation risk, further reinforced by a resilient Piotroski F-Score of 7/9 that signals overall financial strength despite the marginally compressed net return on equity relative to its inputs.

Valuation metrics reflect extreme market divergence from intrinsic value models and historical norms, with a current price-to-earnings ratio of 484.4x vastly outstripping reasonable multiples for an entity generating such thin bottom-line spreads. Discounted cash flow analysis anchors the fair value at $5 per share, implying that the prevailing market price incorporates unrealistic growth assumptions or ignores the drag on capital efficiency inherent in the current business model. This disconnect suggests the stock is priced as a high-growth speculative vehicle rather than a mature income generator, creating significant downside risk if earnings quality does not materially improve to support such elevated multiples over time.

Insider activity introduces an additional layer of caution, with $6.8 million in net selling recorded over the last ninety days, which often precedes or accompanies periods where management anticipates valuation compression. Although the low F-Score and high Z-Score mitigate immediate bankruptcy or fraud concerns, the combination of negligible ROIC, a massive valuation premium, and active insider offloading creates an asymmetric risk-reward profile that challenges traditional investment frameworks relying on sustainable cash flow conversion.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →8%10%12%
2%$8$7$6
3%$9$8$7
4%$10$8$7

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=10.0%, terminal growth 3%. Fair value $8 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

7/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
8.2
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.30
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

74.1%
Gross Margin
0.9%
Net Margin
0.7%
ROIC
+15.5%
Revenue Growth (YoY)
+120.5%
Earnings Growth (YoY)
101.0M
Free Cash Flow

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

0.9%
Net Profit Margin
NI ÷ Revenue
×
0.45x
Asset Turnover
Revenue ÷ Assets
×
1.16x
Equity Multiplier
Assets ÷ Equity
=
0.5%
Return on Equity
Balanced ROE composition across margins, turnover, and leverage.

Balance Sheet Health

0.16x
Debt / Equity
3.13x
Current Ratio
2.4x
Interest Coverage
1.03%
FCF Yield
315.0M
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
-$7M
Net Selling
0
Buy Transactions
15
Sale Transactions
2026-03-26SAMUELSON ERROL GSold 7/7 qtrsGrant7,912 shares
2026-03-26SAMUELSON ERROL GSold 7/7 qtrsSale$209,259
2026-03-24OWENS BRADLEY DSold 7/7 qtrsSale$384,320
2026-03-24OWENS BRADLEY DSold 7/7 qtrsGrant$197,208
2026-03-03BLACHFORD ERIK CASSILSSold 7/7 qtrsSale$41,393

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $0.37
Act: $0.41
+10.8%
Q3
✗ Miss
Est: $0.43
Act: $0.40
-6.9%
Q2
✗ Miss
Est: $0.44
Act: $0.44
-0.3%
Q1
✗ Miss
Est: $0.41
Act: $0.39
-5.6%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

14.7
Forward P/E
PEG Ratio
2.15
Price/Book
4M
Avg Volume
$93.88
52W High
$41.13
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$616M
Tracked Passive Exposure
8
ETFs Holding Z
0.16%
Avg Weight in ETFs
$380B
Total ETF AUM

When investors buy or sell ETFs like ARKF or VNQ, the fund manager is mechanically forced to buy or sell Z shares regardless of Z's individual fundamentals. We estimate $616M of passive capital is structurally linked to Z through 8 tracked ETFs. Passive flows have a limited but growing influence on Z's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in Z to visualize passive redemption contagion across ETFs and collateral stocks.

Z Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
ZEpicenterVBETFVXFETFVNQETFVRTPXUnknownSHOPLow RiskWELLLow RiskPLDMed RiskCOINLow Risk
Z Price Drop (%)0

If Z (Z) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Vanguard Real Estate II Index Fund Institutional Plus Shares (VRTPX) as the most exposed collateral stock, sharing 1 ETFs with Z. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 8 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

Z Ownership Dynamics

Ticker
Z

Float lock-up computed from 9 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

Z Capital Efficiency

How efficiently does Z convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$101M
EBITDA
$315M
FCF Conversion
32%
Reinvestment Rate
68%
32% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)

Z converts 32% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 68% reinvestment rate signals aggressive capacity expansion.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-13322,351$39.63$12.8M
2026-04-087$40.79$285.53
2026-04-071,366$41.65$56,893.9
2026-03-236$43.95$263.7
2026-03-10276,224$45.25$12.5M
2026-03-0622$46.66$1,026.52
2026-03-0546,065$45.82$2.1M
2026-02-237$45.46$318.22
2026-02-1222,558$45.66$1.0M
2026-02-0929,127$54.97$1.6M
2026-02-0629,246$54.01$1.6M
2026-02-05145,294$56.54$8.2M
2026-01-295$65.98$329.9
2026-01-202,147$68.53$147,133.91
2026-01-1694$67.89$6,381.66
2026-01-128$68.75$550
2026-01-0713,704$66.58$912,412.32
2026-01-021,432$68.22$97,691.04
2025-12-22106$68.96$7,309.76
2025-12-1213,991$75.78$1.1M
2025-12-082,725$74.04$201,759
2025-11-26720$74.08$53,337.6
2025-11-2134,726$67.01$2.3M
2025-11-1777$68.80$5,297.6
2025-11-0638$73.03$2,775.14
2025-11-0519$73.03$1,387.57
2025-10-303$71.52$214.56
2025-10-221$77.33$77.33
2025-10-148,353$69.76$582,705.28
2025-10-104,377$70.82$309,979.14

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare Z to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.